Acute Leukemia — Trials

Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

4,653 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,260
Recruiting: 760
Ph III recruiting: 70
Growth YoY: 0%
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (717)

clinicaltrialsPublishedShowing 1–50 of 88 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07044687	Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India	recruiting	Phase 4	100	AbbVieINDUSTRY	1	Sep 11, 2026	clinicaltrials
NCT07773909	Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy	completed	Phase 4	24	Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshOTHER